Abiopharma

🔍 SHERIFF WILLIAM M (Executive)

Company: enCore Energy Corp. (EU)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 101,351 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-17 | Code: A | equity_swap_involved: false | shares_owned_after: 101,351.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 101,351 shares of Stock Option (Right to Buy) at $1.13 per share (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2031-08-17 | equity_swap_involved: false | shares_owned_after: 101,351.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Each restricted stock unit represents the contingent right to receive one common share of enCore Energy Corp.
• F2: On August 17, 2026, the reporting person was granted 101,351 restricted stock units. The restricted stock units vest one-third on August 17, 2027, one-third on August 17, 2028 and one-third on August 17, 2029.
• F3: On August 17, 2026, the reporting person was granted 101,351 stock options. The stock options vest and become exercisable one-third on August 17, 2027, one-third on August 17, 2028 and one-third on August 17, 2029.